Compounds > tibolone
Page last updated: 2024-08-16

tibolone and Adenocarcinoma

tibolone has been researched along with Adenocarcinoma in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's5 (62.50)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kang, SB; Lee, SJ; Park, DC; Yeo, SG1
Arteaga-Gómez, AC; Castellanos-Barroso, G; Colin-Valenzuela, A; García-Vargas, J; Márquez-Acosta, G; Reyes-Muñoz, E1
Contreras, L; Rodriguez, T; Sahid, S; Yazigi, R1
Blok, LJ; Burger, CW; De Gooyer, ME; Gielen, SC; Hanifi-Moghaddam, P; Kloosterboer, HJ; Moorhouse, M; Sijbers, AM; Smid, M; van Gool, AJ; van Wijk, FH1
Khalil, AM; Nassar, AH; Seoud, MA; Usta, IM1
Bracke, ME; Depypere, HT; Kloosterboer, HJ; Vanhoecke, BW1
Archer, DF; Mirkin, S1
Gillmer, MD; Gray, MD; McEwan, HP; Pyper, RJ; Rollason, TP; von Dadelszen, P; Wright, A1

Other Studies

8 other study(ies) available for tibolone and Adenocarcinoma

ArticleYear
Attitudes and practices of Korean gynecologists towards hormone replacement therapy in endometrial cancer survivors.
    European journal of gynaecological oncology, 2013, Volume: 34, Issue:6

    Topics: Adenocarcinoma; Adult; Attitude of Health Personnel; Endometrial Neoplasms; Estrogen Receptor Modulators; Female; Gynecology; Hormone Replacement Therapy; Humans; Hysterectomy; Male; Menopause, Premature; Middle Aged; Neoplasm Grading; Neoplasm Staging; Norpregnenes; Ovariectomy; Practice Patterns, Physicians'; Republic of Korea; Salpingectomy; Surveys and Questionnaires; Time Factors

2013
[Hormone therapy effect in postmenopausal women with history of endometrial cancer].
    Ginecologia y obstetricia de Mexico, 2011, Volume: 79, Issue:1

    Topics: Adenocarcinoma; Adult; Carcinoma, Adenosquamous; Carcinoma, Endometrioid; Comorbidity; Diabetes Mellitus, Type 2; Endometrial Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Hypertension; Middle Aged; Neoplasm Staging; Norpregnenes; Postmenopause; Recurrence; Retrospective Studies; Smoking

2011
Carcinoma of the endometrium in patients treated with tibolone.
    Gynecologic oncology, 2004, Volume: 93, Issue:2

    Topics: Adenocarcinoma; Aged; Anabolic Agents; Androgen Antagonists; Endometrial Neoplasms; Estrogen Receptor Modulators; Female; Humans; Middle Aged; Norpregnenes

2004
Molecular portrait of the progestagenic and estrogenic actions of tibolone: behavior of cellular networks in response to tibolone.
    The Journal of clinical endocrinology and metabolism, 2005, Volume: 90, Issue:2

    Topics: Adenocarcinoma; Cell Differentiation; Cell Division; Cell Line, Tumor; Endometrial Neoplasms; Estradiol; Estrogen Receptor Modulators; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Nerve Net; Norpregnenes; Progestins; Transcription, Genetic

2005
Endometrial adenocarcinoma after prolonged tibolone therapy.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2005, Volume: 90, Issue:1

    Topics: Adenocarcinoma; Brachytherapy; Diagnosis, Differential; Drug Administration Schedule; Endometrial Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norpregnenes; Postmenopause; Uterine Hemorrhage

2005
Tibolone and its metabolites inhibit invasion of human mammary carcinoma cells in vitro.
    Maturitas, 2006, Jun-20, Volume: 54, Issue:3

    Topics: Adenocarcinoma; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Estrogen Receptor Modulators; Female; Humans; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Norpregnenes; Osteoporosis, Postmenopausal

2006
Effects of tibolone and its metabolites on Angiopoietin-1, Tie-2 and tumor necrosis factor-alpha mRNA in Ishikawa cells. Implication for tibolone's effects on the endometrium.
    Maturitas, 2007, Aug-20, Volume: 57, Issue:4

    Topics: Adenocarcinoma; Angiopoietin-1; Cell Line, Tumor; Contraceptive Agents, Female; Endometrial Neoplasms; Endometrium; Estradiol; Estrogen Receptor Modulators; Female; Humans; Medroxyprogesterone Acetate; Norpregnenes; Receptor, TIE-2; Receptors, Estrogen; Receptors, Progesterone; RNA, Messenger; Tumor Necrosis Factor-alpha

2007
Endometrial hyperplasia and adenocarcinoma during tibolone (Livial) therapy.
    British journal of obstetrics and gynaecology, 1994, Volume: 101, Issue:2

    Topics: Adenocarcinoma; Aged; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Menopause; Middle Aged; Norpregnenes

1994